A thickened formula does not reduce apneas related to gastroesophageal reflux in preterm infants

Neonatology. 2013;103(2):98-102. doi: 10.1159/000342703. Epub 2012 Nov 20.

Abstract

Background: Apnea of prematurity (AOP) occurs frequently in preterm infants and a variable proportion of AOP can be induced by gastroesophageal reflux (GER). Conservative treatment, including dietary modifications, should be the first-line approach for both GER and GER-related apneas in this population.

Objectives: To evaluate the efficacy of a starch-thickened preterm formula (PF) in reducing the frequency of apneas related to GER.

Methods: Preterm infants with AOP were studied by combined impedance and pH monitoring and polysomnography. The 6-hour study period included two feeds, one of a commercially available PF and one of the same formula thickened with amylopectin (TPF). GER indexes, apneas and GER-related apneas detected after TPF and PF feeds were compared by Wilcoxon signed-rank test.

Results: 24 infants were studied. During 140 h of registration, 289 apneas (147 after TPF and 142 after PF; p = 0.876), and 861 GER episodes (400 after TPF and 461 after PF; p = 0.465) were recorded. No difference in the number of AOP was found between TPF and PF. A significant reduction in acid exposure was found after TPF; there was no influence on non-acid GER indexes. The frequency of GER-related apneas did not differ between TPF and PF.

Conclusions: A formula thickened with amylopectin did not reduce the number of AOP or GER-related apneas. It reduced acid GER features but had no effect on non-acid GER indexes. Future research should focus on exploring different conservative strategies to treat GER-related apneas in preterm infants.

MeSH terms

  • Apnea / etiology
  • Apnea / prevention & control*
  • Female
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / diagnosis
  • Gastroesophageal Reflux / prevention & control*
  • Gestational Age
  • Humans
  • Hydrogen-Ion Concentration
  • Infant Formula / administration & dosage*
  • Infant Formula / chemistry*
  • Infant, Newborn
  • Infant, Premature*
  • Infant, Premature, Diseases / prevention & control*
  • Male
  • Polysomnography
  • Viscosity